본문 바로가기
KERD
논문KCI 등재

의약품부작용보고시스템을 이용한 바레니클린의 이상사례 실마리정보 도출

Signal detection for adverse event of varenicline in Korea Adverse Event Reporting System

구현진|김준우|신광희|장민교
한국임상약학회 (Korean College Of Clinical Pharmacy)|2022.03|한국임상약학회지 (Korean Journal of Clinical Pharmacy)|제32권 제1호|pp. 1-7|DOI 10.24304/kjcp.2022.32.1.1

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

data miningsmoking cessationsignal detectionAdverse eventvarenicline
주제분류약학

초록

Objective: The purpose of this study was to detect signals of Adverse Events (AEs) after varenicline treatment using spontaneous AEs reporting system in Korea. Methods: This study was conducted by Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database (KIDS-KD) reported from January 2013 to December 2017 through Korea Adverse Event Reporting System. Signals of varenicline that satisfied the data-mining indices, proportional reporting ratio, reporting odds ratio and information component were defined. The detected signals were checked whether they included in drug labels in South Korea and United States of America (USA). Results: A total number of drug AE reports associated with all drugs in the KIDS-KD reported between January 2013 and December 2017 was 2,665,429. Among them, the number of AE reports associated with varenicline was 1,398. Eighteen meaningful signals of varenicline were detected that satisfied with the criteria of data-mining indices. Finally, two signals such as hypotonia, incorrected dose administered were not included in the drug labels. Conclusion: New AE signals of varenicline that were not listed on the drug labels in South Korea and USA were detected. However, further pharmacoepidemiological studies such as randomized controlled trial are needed to evaluate the causality of the signals of varenicline.

Abstract

Objective: The purpose of this study was to detect signals of Adverse Events (AEs) after varenicline treatment using spontaneous AEs reporting system in Korea. Methods: This study was conducted by Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database (KIDS-KD) reported from January 2013 to December 2017 through Korea Adverse Event Reporting System. Signals of varenicline that satisfied the data-mining indices, proportional reporting ratio, reporting odds ratio and information component were defined. The detected signals were checked whether they included in drug labels in South Korea and United States of America (USA). Results: A total number of drug AE reports associated with all drugs in the KIDS-KD reported between January 2013 and December 2017 was 2,665,429. Among them, the number of AE reports associated with varenicline was 1,398. Eighteen meaningful signals of varenicline were detected that satisfied with the criteria of data-mining indices. Finally, two signals such as hypotonia, incorrected dose administered were not included in the drug labels. Conclusion: New AE signals of varenicline that were not listed on the drug labels in South Korea and USA were detected. However, further pharmacoepidemiological studies such as randomized controlled trial are needed to evaluate the causality of the signals of varenicline.

참고문헌 (40)

  1. Samet JM, "Tobacco smoking : the leading cause of preventable disease worldwide", Thorac Surg Clin, 23(2), pp.103~112 (2013)
  2. Reitsma MB, "Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015", Lancet, 389(10082), pp.1885~1906 (2017)
  3. Stanaway JD, "Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392(10159), pp.1923~1994 (2018)
  4. Hughes JR, "Shape of the relapse curve and longterm abstinence among untreated smokers", Addiction, 99(1), pp.29~38 (2004)
  5. Lee CM, "Pharmacotherapy to Quit : Beyond the Guidelines", J Korean Soc Res Nicotine Tob, 6(1), pp.10~17 (2015)
  6. Hughes JR, "Relapse to smoking after 1 year of abstinence : a meta-analysis", Addict Behav, 33(12), pp.1516~1520 (2008)
  7. Linxiang T, "Nicotine dependence and smoking cessation", Zhong Nan Da Xue Xue Bao Yi Xue Ban, 34(11), pp.1049~1057 (2009)
  8. Fiore MC, "Treating tobacco use and dependence : 2008 update US public health service clinical practice guideline executive summary", Respir Care, 53(9), pp.1217~1222 (2008)
  9. García-Gómez L, "Smoking cessation treatments : current psychological and pharmacological options", Rev Invest Clin, 71(1), pp.7~16 (2019)
  10. 백유진, "금연치료 최신지견", 대한의사협회지, 59(11), pp.872~880 (2016), 대한의사협회[DOI]
  11. Jiménez-Ruiz C, "Varenicline : a novel pharmacotherapy for smoking cessation", Drugs, 69(10), pp.1319~1338 (2009)
  12. "Searching for information such as medicines"[URL]
  13. Rouve N, "Prescribed drugs and violence : a case", noncase study in the French PharmacoVigilance Database, 2011, pp.67(11), 1189~1198
  14. Motooka Y, "Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the Food and Drug Administration Adverse Event Reporting System, 2004-2016", SAGE Open Med, 6, pp.1~11 (2018)
  15. Moore TJ, "Prescription drugs associated with reports of violence towards others", PloS one, 5(12), pp.e15337~ (2010)
  16. Moore TJ, "Thoughts and acts of aggression", violence toward others reported in association with varenicline, 2010, pp.44(9), 1389~1394
  17. 최남경, "우리나라 약물유해반응 감시체계", 예방의학회지, 40(4), pp.278~284 (2007), 대한예방의학회
  18. Park HH, "Gender differences in the adverse events associated with cardiovascular drugs in a spontaneous reporting system in South Korea", Int J Clin Pharm, 43(4), pp.1036~1044 (2021)
  19. 임경화, "의약품 부작용에 관한 국제 분류체계인 WHO-ART와 MedDRA의 비교분석", 한국임상약학회지, 17(1), pp.46~52 (2007), 한국임상약학회
  20. 김묘송, "국내 사람유두종바이러스백신 접종 후 자발적 이상반응 보고사례의 Brighton Collaboration 기준 활용 가능성 연구", 한국임상약학회지, 30(1), pp.19~30 (2020), 한국임상약학회[DOI]
  21. 오솔, "완화의료병동 암환자들의 섬망 치료를 위해 사용된 항정신병 약물의 효과 및 안전성 비교", 한국임상약학회지, 30(2), pp.92~101 (2020), 한국임상약학회[DOI]
  22. 채규한, "의약품 안전성 관리를 위한 연구- 의약품 안전관리 제도개선 방안을 중심으로 -", 약 학 회 지, 57(3), pp.173~186 (2013), 대한약학회
  23. "Search for product information"[URL]
  24. "FDA label search" (2021)[URL]
  25. Kim S, "Data-mining for detecting signals of adverse drug reactions of fluoxetine using the Korea Adverse Event Reporting System(KAERS)database", Psychiatry Res, 256, pp.237~242 (2017)
  26. 이미우, "데이터마이닝 분석을 이용한 노인약물유해반응과 원인약물의 연관성연구", 한국임상약학회지, 24(1), pp.39~44 (2014), 한국임상약학회
  27. Seo DE, "Signals of adverse drug reactions of paliperidone compared to other atypical antipsychotics using the Korean Adverse Event Reporting System Database", Clin Drug Investig, 40(9), pp.873~881 (2020)
  28. Ha D, "Comparison of signal detection of tumour necrosis factor-α inhibitors using the Korea Adverse Events Reporting System Database, 2005-2016", Clin Rheumatol, 39(2), pp.347~355 (2020)
  29. Lummis SCR, "Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor", J Pharmacol Exp Ther, 339(1), pp.125~131 (2011)
  30. Thompson AJ, "5-HT3 receptors", Curr Pharm Des, 12(28), pp.3615~3630 (2006)
  31. Price KL, "Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP", ACS Chem Neurosci, 6(7), pp.1151~1157 (2015)
  32. Faessel HM, "A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation", Clin Pharmacokinet, 49(12), pp.799~816 (2010)
  33. Tonstad S, "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations", Curr Med Res Opin, 36(5), pp.713~730 (2020)
  34. Kuehn BM, "Studies linking smoking-cessation drug with suicide risk spark concerns", JAMA, 301(10), pp.1007~1008 (2009)
  35. Moore TJ, "Suicidal behavior and depression in smoking cessation treatments", PLoS One, 6(11), pp.e27016~ (2011)
  36. Anthenelli RM, "Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial", Lancet, 387(10037), pp.2507~2520 (2016)
  37. Evins AE, "Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES Trial", J Clin Psychopharmacol, 39(2), pp.108~116 (2019)
  38. Foulds J, "The neurobiological basis for partial agonist treatment of nicotine dependence : varenicline", Int J Clin Pract, 60(5), pp.571~576 (2006)
  39. Uca AU, "Varenicline-induced acute dystonic reaction : a case report", Gen Hosp Psychiatry, 36(3), pp.361~ (2014)
  40. Abou-Zeid E, "Lambert-Eaton myasthenic syndrome following varenicline(Chantix)use", Muscle Nerve, 40(3), pp.486~487 (2009)

관련 논문AI추천

의약품부작용보고시스템을 이용한 메토클로프라미드의 이상사례 실마리정보 도출신광희, 이영화, 장민교, 정현숙한국임상약학회 · 한국임상약학회지2023 · 제33권 제2호의약품부작용보고시스템 데이터베이스를 이용한 졸피뎀 약물 유해반응 실마리 정보 검출고영진, 김선지, 박병주, 한준우한국보건의료기술평가학회 · 보건의료기술평가2018 · 제6권 제1호Signal Detection of DPP-IV Inhibitors using Spontaneous Adverse Event Reporting System in Korea강해리, 곽혜선, 김정선, 김태영, 조형준, 최수빈, 표혜정, 한지민한국임상약학회 · 한국임상약학회지2024 · 제34권 제2호Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database권경은, 김정미, 박경훈, 박병주, 양보람, 이중엽, Mick Soukavong, Xue-mei Jin연세대학교의과대학 · Yonsei Medical Journal2017 · 제58권 제3호Spontaneous Reporting of Adverse Drug Reactions through Electronic Submission from Regional Society Healthcare Professionals in Korea문현주, 박경희, 박중원, 이용원, 이재현, 홍천수연세대학교의과대학 · Yonsei Medical Journal2012 · 제53권 제5호텍스트마이닝을 이용한 약물유해반응 보고자료 분석김현희, 유기연한국임상약학회 · 한국임상약학회지2017 · 제27권 제4호

이 간행물의 다른 논문 (6건)

국내 약학대학 학생들의 표준화 환자를 활용한 복약상담 교 육및 OSCE에 대한 인식박태은, 강민구pp. 8-12SGLT2 저해제/metformin 고정용량복합제의 국내 사용 현황정경혜, 제남경, 이지원, 최하은pp. 13-19상급종합병원 병동담당약사 업무 현황 및 의료인의 인식과 기대 분석김정은, 이정화, 백시진, 전수정, Eunkyung Euni Lee, 이주연, 남궁형욱, 최나예pp. 20-26Transitional care for high-risk elderly patients pre/post discharge by collaboration between general hospital and community pharmacy: a pilot study박미선, 이흥범, 김주신, 최은주, 이지희pp. 27-36비판막성심방세동 환자에서 직접작용 경구용 항응고제 임상적 효과와 부작용 연구홍지원, 이숙향, 정민지pp. 37-46
원문 보기